[Sigia-l] IA in Biotech

[Lord, Ralph]

The team I work on in the Division of Public Health Surveillance and
Informatics produces what is essentially a database front-end which is used
by many clinics, hospitals and other health professionals around the world
to collect and manage patient data.  Although Epi Info was originally
designed as a tool for field epidemiology and ran under DOS, the Windows
version has quickly been adopted as a "quick and dirty" clinical management
tool.  Because it enables the users to create their own UI's and database
structure, I see lots of IA issues in the systems which they produce for
their own informatics needs.  Adding an IA-type module to our training is
under consideration.



> -----Original Message-----
> From: Margaret Hanley [mailto:mairead at yahoo.com]
> Sent: Thursday, May 30, 2002 3:58 AM
> To: Ziya Oz; ASIS
> Subject: Re: [Sigia-l] IA in Biotech
> 
> 
> My company Ingenta is involved in an EU sponsored
> BioInformatics projects which is being developed over the
> next three years. The aim is to link factual (protein,
> sequence and nucleotide databases), literature and image
> databases together in one resource.
> 
> And we have had IA resources assigned. It is just the
> beginning  of the project, so keep an eye on
> http://www.e-biosci.org.
> 
> Mags
> 
>  --- Ziya Oz <ZiyaOz at earthlink.net> wrote: > I was reading
> in BioIT World (Oracle CEO) Larry Ellison's
> > inimitable views
> > on privacy and the clinical trial process:
> > 
> > "You think your health records are private. I'll tell you
> > what - half your
> > health records are private because they're lost. The
> > other half are in a
> > manila envelope, sitting on a shelf, being read by a
> > 16-year-old who's
> > working part-time for your doctor, bored to death,''
> > Ellison said.
> > [...]
> > "If a million people go untreated and die, the FDA thinks
> > that's OK. If a
> > million people get treated with a drug, and many are
> > saved but two people
> > are killed by the drug, then the FDA thinks that's really
> > bad," Ellison
> > said. "It is really scandalous today that the FDA is so
> > cautious about the
> > delivery of a drug that may have such a bad side effect,
> > and therefore so
> > slow taking drugs through clinical trials. If we had the
> > clinical records,
> > then I could screen you for toxicity for this drug."
> > 
> > <http://www.bio-itworld.com/news/050702_report260.html>
> > 
> > It's no secret that information management and delivery
> > is a huge issue in
> > this field. Is there anyone here involved with IA (not so
> > much broadly in
> > healthcare but more specifically) in biotech and
> > bioinformatics?
> > 
> > Best,
> > 
> > Ziya
> > 
> > ------------
> > When replying, please TRIM YOUR POST as much as possible.
> > 
> > PLAIN TEXT, please; NO Attachments
> > 
> > ASIST SIG IA: Http://www.asis.org/SIG/SIGIA/index.html
> > _______________________________________________
> > Sigia-l mailing list
> > Sigia-l at asis.org
> > http://mail.asis.org/mailman/listinfo/sigia-l 
> 
> __________________________________________________
> Do You Yahoo!?
> Everything you'll ever need on one web page
> from News and Sport to Email and Music Charts
> http://uk.my.yahoo.com
> ------------
> When replying, please TRIM YOUR POST as much as possible.
> 
> PLAIN TEXT, please; NO Attachments
> 
> ASIST SIG IA: Http://www.asis.org/SIG/SIGIA/index.html
> _______________________________________________
> Sigia-l mailing list
> Sigia-l at asis.org
> http://mail.asis.org/mailman/listinfo/sigia-l
>